Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steatotic Liver Disease”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableStudy completedNCT07211113
What this trial is testing

Effects of Long-lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcome

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of Campania Luigi Vanvitelli 87
Post-approval studies (Phase 4)Enrolling By InvitationNCT07274644
What this trial is testing

Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseDiabetes Mellitus Type 2
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 36
Not applicableNot Yet RecruitingNCT07270822
What this trial is testing

Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes

Who this might be right for
Steatotic Liver DiseaseFibrosis of Liver
Hospices Civils de Lyon 1,714
Not applicableNot Yet RecruitingNCT06453239
What this trial is testing

Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

Who this might be right for
Steatosis of Liver
Sohag University 80
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableNot Yet RecruitingNCT07412444
What this trial is testing

EVOO and Metabolic Liver Health in MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseOverweight
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Very early researchLooking for participantsNCT07381257
What this trial is testing

Efficacy and Safety of Rifaximin-α in Treating MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai Changzheng Hospital 60
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Not applicableLooking for participantsNCT06867419
What this trial is testing

Metabolic Features Effects on FAST Score in MASLD Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Tanta University 385
Testing effectiveness (Phase 2)Active Not RecruitingNCT06465186
What this trial is testing

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNAFLD+2 more
Merck Sharp & Dohme LLC 80
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableEnrolling By InvitationNCT06514300
What this trial is testing

Investigating Myosteatosis in Steatotic Liver Diseases

Who this might be right for
Alcohol-related Liver DiseaseMetabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver Disease of Mixed Origin (MetALD)+5 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Large-scale testing (Phase 3)UnknownNCT06759363
What this trial is testing

MASLD Butyrate Supplementation Treatment Efficacy Review

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University Medical Center Zvezdara 200
Not applicableEnrolling By InvitationNCT07001865
What this trial is testing

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolically Healthy ObesityHyperuricemia
Ningbo No. 1 Hospital 17,040
Not applicableLooking for participantsNCT06676813
What this trial is testing

Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 72
Testing effectiveness (Phase 2)Looking for participantsNCT06355310
What this trial is testing

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Justin Ryder 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Load More Results